|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7125 | |||
| A61P 31/14 |
| (11) | Number of the document | 2992095 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14729529.9 |
| Date of filing the European patent application | 2014-04-30 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/036137 |
| Date | 2014-04-30 |
| (87) | Number | WO 2014/179446 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 201361818432 P | 2013-05-01 | US | |
| 201361822112 P | 2013-05-10 | US | |
| 201361839550 P | 2013-06-26 | US | |
| 201361895784 P | 2013-10-25 | US | |
| 201361898704 P | 2013-11-01 | US | |
| 201461927897 P | 2014-01-15 | US |
| (72) |
BHAT, Balkrishen, US
HOGAN, Daniel, US
|
| (73) |
Regulus Therapeutics Inc.,
10614 Science Center Drive, San Diego, CA 92121,
US
|
| (54) | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-122 |
| MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-122 |